GOSS
Gossamer Bio Inc.
Latest News for GOSS
Gossamer (GOSS) told investors its Phase 3 PROSERA study was progressing, with executives expressing confidence in the trial’s design and patient s......
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Gossamer Bio (GOSS) and Biogen (BIIB). Gossamer Bio (GOSS) In a r......
Escalating tensions in the Middle East, a spike in crude prices, and signs of fatigue in the U.S. labor market are fueling fresh analyst chatter ab......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Gossamer Bio (GOSS) and Silexion Therapeutics (SLXN)......
Gossamer Bio, Vital Farms, and Oklo could make for high-upside defensive plays as stagflation risk returns to Wall Street. ...
News data is sourced from MarketXLS API and updated regularly.
Showing 5 of 5 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GOSS | $0.33 | 0% | 8.23M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |